4211

Comparison of human cardiac 31P-MRS on 3 T Trio and Prisma scanners
Jane Ellis1, Moritz Hundertmark1, Marco Spartera1, William Watson1, Christopher T. Rodgers1,2, and Ladislav Valkovic1,3

1OCMR, RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom, 2Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom, 3Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia

Synopsis

Cardiac PCr/ATP ratios measured by 31P MRS are a measure of the biochemical “energy reserve” in the heart. They decrease early in the progression of a wide range of diseases, making them a valuable biomarker. Logistically, it is often important for a long-running study to be able to compare data acquired on different MRI scanners. In this study, we show that comparable results may be acquired with 3T Prisma and 3T Trio scanners by scanning 10 healthy volunteers with 31P-CSI and 31P-DRESS on both systems. It is legitimate to pool 3T Prisma and 3T Trio data for clinical studies.

Purpose

In most major heart diseases the ratio of phosphocreatine (PCr) to adenosine triphosphate (ATP) concentrations, i.e. PCr/ATP, is impaired. So, PCr/ATP is a useful indicator of the energetic state of the heart.1,2 PCr/ATP can be assessed using 3T 31P-MRS. Two widely-used localization sequences are 3D chemical shift imaging (3D-CSI) and 1D depth-resolved spectroscopy (DRESS).3 Many studies run longitudinally, or can gain value from comparing to substantial historic datasets. However, the pace of MR technology continues and we, as well as many other centres who apply 31P-MRS, have recently installed a new 3T Prisma (Siemens) MRI scanner to complement, or replace, an ageing 3T Trio (Siemens) scanner. These new systems are not always equipped with the same RF-coils making pooling of existing and newly acquired data even more questionable.

Therefore, the aim of this study was to assess whether PCr/ATP measurements obtained using two different models of 3T MRI scanner, together with different surface coils from different manufacturers can be pooled together. Data from this work will be important for the design of future clinical studies.

Methods

Data acquisition 10 healthy volunteers (4F, age 30 ± 4yrs, BMI 24.4 ± 4.0 kg/m2) were recruited according to local regulations. The scanning protocol is given in Figure 1. Six of the 10 subjects completed the full protocol; four subjects were only scanned with the 3D UTE-CSI sequences. The UTE-CSI sequence followed a published protocol,4 with the following parameters: matrix size 8x16x8; FOV 240x240x200mm3; acquisition weighting with 10 averages at k=0, and a shaped excitation pulse. Three B1-insensitive train to obliterate signal (BISTRO), saturation bands were placed covering anterior chest wall (to suppress signal from skeletal muscle) and liver.5 The TR was ~720ms (varied to give maximum SAR), giving a total acquisition time of approximately 10 minutes. The DRESS sequence used an 800µs duration sinc excitation pulse; slice thickness 20mm; TE = 1ms; TR = 1000ms and 180 averages, leading to an acquisition time of 3 minutes.

We used three 31P RF coils in our comparison:

  1. A “heart-liver” coil (a 1.5T Siemens,retuned for 3T), comprising a large rectangular (28x26cm2) element which acts as a local transmit/receive 1H coil and the 31P transmit coil; a second “loop-butterfly” quadrature pair acts as the 31P receive element. This coil was used to acquire the “Trio-CSI-HL” data set.
  2. A 10cm loop coil (PulseTeq, Chobham, UK), comprising a 31P only transmit/receive coil with an inductively driven single circular 10 cm diameter loop element. This coil is used to acquire the “Trio-DRESS-10cm” data set.
  3. A “flex coil” (Rapid Biomedical, Rimpar, Germany), comprising a 1H butterfly transmit/receive element and a 31P 11cm diameter transmit/receive circular loop. This was used to acquire the "Prisma-" data sets.

Data analysis: Data were fitted using the Oxford Spectroscopy Analysis (OXSA) toolbox6 for all subjects. Prior knowledge specified 11 Lorentzian peaks, linewidths constrained relative to the PCr linewidth, and literature values for the scalar couplings for the multiplets. Blood contamination and partial saturation was then corrected using T1 values and the blood DPG/ATP ratio from the literature.7

Assessment of reproducibility: The coefficient of reproducibility (CR) was calculated according to:

$$CR = SD\tiny intrasubject\normalsize \times1.96$$

A smaller CR reflects a better method. Statistical significance was tested for using a two-tailed Student’s t-test. We considered P <0.05 to be significant.

Results and discussion

There were no significant differences in PCr/ATP measured using either scanner, coil, or sequence (Figure 3). We found good reproducibility (Fig. 4) of the 3D-CSI sequence on the Prisma (CR=0.35), and good agreement in measurements between both scanners (CR=0.37) meaning that measurements from these two systems can be compared.

There is greater scatter in PCr/ATP measurements using DRESS compared to the 3D-CSI sequence, this is to be expected owing to the shorter acquisition time of these data-sets. We believe that some of our DRESS measurements, e.g. those with PCr/ATP >3 are likely to have skeletal muscle contamination in the supposedly “cardiac” spectra. We did not use any saturation bands here; in future DRESS studies, we recommend applying a saturation band to suppress signal from the anterior chest wall to reduce the chance of skeletal muscle contamination.

In this study, we were able to test only Siemens scanners operating at 3T. Further validation would be required to pool data across field strengths, or to other makes/models of scanners.

Conclusion

We have shown that PCr/ATP measurements on two different 3T scanners using different surface coil designs are reproducible. This is particularly important for clinical studies, as it means that data from the two scanners can be pooled without compromising the study outcome.

Acknowledgements

Funded by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society to CTR [098436/Z/12/B]. JE receives a DPhil studentship from the Medical Research Council (UK). The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The support of the Slovak Grant Agency VEGA (grant #2/0001/17) and APVV (grant #15-0029) is also acknowledged.

References

1. Neubauer S. The failing heart--an engine out of fuel. N Engl J Med. 2007;356(11):1140–1151. doi:10.1056/NEJMra063052.

2. Bottomley PA, Bottomley, A. P. MRS Studies of Creatine Kinase Metabolism in Human Heart. In: eMagRes. Chichester, UK: John Wiley & Sons, Ltd; 2016:1183–1202. doi:10.1002/9780470034590.emrstm1488.

3. Bottomley PA, Foster TB, Darrow RD. Depth-resolved surface-coil spectroscopy (DRESS) for in Vivo1H, 31P, and 13C NMR. J Magn Reson. 1984;59(2):338–342. doi:10.1016/0022-2364(84)90179-3. 4. Tyler DJ, Emmanuel Y, Cochlin LE, et al. Reproducibility of 31 P cardiac magnetic resonance spectroscopy at 3 T. NMR Biomed. 2009;22(4):405–413. doi:10.1002/nbm.1350.

5. Luo Y, de Graaf RA, DelaBarre L, Tannús A, Garwood M. BISTRO: An outer-volume suppression method that tolerates RF field inhomogeneity. Magn Reson Med. 2001;45(6):1095–1102. doi:10.1002/mrm.1144.

6. Purvis LAB, Clarke WT, Biasiolli L, Valkovič L, Robson MD, Rodgers CT. OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB. Motta A, red. PLoS One. 2017;12(9):e0185356. doi:10.1371/journal.pone.0185356.

7. Rodgers CT, Clarke WT, Snyder C, Vaughan JT, Neubauer S, Robson MD. Human cardiac 31 P magnetic resonance spectroscopy at 7 tesla. Magn Reson Med. 2014;72(2):304–315. doi:10.1002/mrm.24922.

Figures

Study protocol. The first scan was in a 3T Trio: we obtained a PCr/ATP measurement (“Trio-CSI-HL”) using a 3D-CSI sequence with subjects prone on a heart-liver coil. Next, we repositioned the subjects supine and obtained a second PCr/ATP (“Trio-DRESS-10cm”), using the DRESS sequence and a 10cm loop coil. After a short (~5 min) break, subjects moved to the 3T Prisma. We scanned subjects supine with a “flex” coil and acquired both 3D-CSI (“Prisma-CSI-flex-1”) and DRESS measurements (“Prisma-DRESS-flex-1”) in a single session. Subjects were removed from the magnet and we repeated the Prisma scan to obtain two more data-sets (“Prisma-CSI-flex-2”, “Prisma-DRESS-flex-1”).

Example cardiac spectra from the same subject from both sequences and scanners.

PCr/ATP of each subject measured using either A 3D-CSI or B DRESS sequence on a 3T Trio and 3T Prisma. Error bars at sides mark mean and standard deviation. Data-set ‘Trio-CSI-HL’ measured prone with heart-liver coil, the rest measured supine with either a 10cm loop coil (Trio) or “flex” coil (Prisma). There are no significant differences in PCr/ATP (P>0.05, paired t-test) between any pairs of data-sets.

Bland Altman plots. Blue lines mark the bias, black lines mark ±1.96SD.

Proc. Intl. Soc. Mag. Reson. Med. 27 (2019)
4211